Walleye Trading LLC Crispr Therapeutics Ag Call Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$44.62 - $62.75 $62,468 - $87,850	-1,400 Reduced 4.61%	29,000 $1.36 Million
Q2 2024 Aug 14, 2024	SELL	$51.17 - $68.18 $1.19 Million - $1.58 Million	-23,200 Reduced 43.28%	30,400 $1.64 Million
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $3.57 Million - $5.24 Million	-58,800 Reduced 52.31%	53,600 $3.65 Million
Q4 2023 Feb 14, 2024	SELL	$38.62 - $72.18 $142,894 - $267,066	-3,700 Reduced 3.19%	112,400 $7.04 Million
Q3 2023 Nov 14, 2023	SELL	$45.39 - $59.0 $1.53 Million - $1.99 Million	-33,800 Reduced 22.55%	116,100 $5.27 Million
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $2.54 Million - $3.96 Million	-58,500 Reduced 28.07%	149,900 $8.42 Million
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $4.69 Million - $6.43 Million	-114,500 Reduced 35.46%	208,400 $9.43 Million
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $940,560 - $1.58 Million	24,000 Added 8.03%	322,900 $13.1 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $8 Million - $11 Million	131,000 Added 78.02%	298,900 $19.5 Million
Q2 2022 Aug 08, 2022	BUY	$43.23 - $73.83 $1.15 Million - $1.97 Million	26,700 Added 18.91%	167,900 $10.2 Million
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $4.92 Million - $7.33 Million	92,500 Added 189.94%	141,200 $8.86 Million
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $939,206 - $1.49 Million	-13,400 Reduced 21.58%	48,700 $3.69 Million
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $1.01 Million - $1.44 Million	9,200 Added 17.39%	62,100 $6.95 Million
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $242,016 - $388,535	-2,400 Reduced 4.34%	52,900 $8.56 Million
Q1 2021 May 17, 2021	BUY	$110.72 - $210.04 $4.54 Million - $8.61 Million	41,000 Added 286.71%	55,300 $6.74 Million
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $191,208 - $415,752	2,400 Added 20.17%	14,300 $2.19 Million
Q3 2020 Nov 16, 2020	BUY	$78.5 - $100.64 $23,550 - $30,192	300 Added 2.59%	11,900 $995,000
Q2 2020 Aug 14, 2020	SELL	$38.5 - $76.05 $323,400 - $638,820	-8,400 Reduced 42.0%	11,600 $852,000
Q1 2020 May 15, 2020	SELL	$33.68 - $62.53 $872,312 - $1.62 Million	-25,900 Reduced 56.43%	20,000 $848,000
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $1.14 Million - $2.27 Million	31,000 Added 208.05%	45,900 $2.8 Million
Q3 2019 Nov 14, 2019	SELL	$40.99 - $52.56 $1.11 Million - $1.43 Million	-27,200 Reduced 64.61%	14,900 $611,000
Q2 2019 Aug 14, 2019	BUY	$35.45 - $48.2 $1.29 Million - $1.75 Million	36,300 Added 625.86%	42,100 $1.98 Million
Q1 2019 May 15, 2019	SELL	$28.02 - $40.87 $563,202 - $821,487	-20,100 Reduced 77.61%	5,800 $207,000
Q4 2018 Feb 14, 2019	BUY	$22.73 - $42.34 $520,517 - $969,586	22,900 Added 763.33%	25,900 $740,000
Q3 2018 Nov 14, 2018	BUY	$44.35 - $65.71 $133,050 - $197,129	3,000 New	3,000 $133,000

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$306 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$290 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$116 Million
0.01% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$115 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$115 Million
1.61% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.02B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account